Free Trial

Acacia Research (NASDAQ:ACTG) Stock Price Passes Above 200-Day Moving Average - Should You Sell?

Acacia Research logo with Business Services background
Image from MarketBeat Media, LLC.

Key Points

  • Technical move: Acacia's share price crossed above its 200‑day moving average ($4.03) during trading, reaching as high as $5.01 and last trading around $4.83 on volume of ~346,072 shares.
  • Fundamentals beat: The company beat quarterly expectations with EPS of $0.03 (vs. -$0.14) and revenue of $50.13M (vs. $38M), and shows strong liquidity (quick ratio 8.64, current ratio 9.18) with low leverage (debt/equity 0.10).
  • Mixed analyst view: Brokerages are divided—one Buy and one Hold—yet the consensus is a Moderate Buy with an average price target of $6.00 (Craig Hallum raised its target to $6.00 and rated the stock Buy).
  • Five stocks we like better than Acacia Research.

Acacia Research Corporation (NASDAQ:ACTG - Get Free Report)'s share price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $4.03 and traded as high as $5.01. Acacia Research shares last traded at $4.83, with a volume of 346,072 shares.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on ACTG. Weiss Ratings raised Acacia Research from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Friday, March 13th. Wall Street Zen downgraded Acacia Research from a "buy" rating to a "hold" rating in a research note on Saturday, March 14th. Finally, Craig Hallum increased their price objective on Acacia Research from $5.00 to $6.00 and gave the stock a "buy" rating in a research note on Thursday, March 12th. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $6.00.

Read Our Latest Report on ACTG

Acacia Research Trading Down 2.8%

The company has a quick ratio of 8.64, a current ratio of 9.18 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $465.95 million, a PE ratio of 21.00 and a beta of 0.44. The firm has a 50 day moving average price of $4.65 and a 200 day moving average price of $4.03.

Acacia Research (NASDAQ:ACTG - Get Free Report) last issued its quarterly earnings results on Wednesday, March 11th. The business services provider reported $0.03 EPS for the quarter, beating analysts' consensus estimates of ($0.14) by $0.17. The company had revenue of $50.13 million during the quarter, compared to the consensus estimate of $38.00 million. Acacia Research had a return on equity of 4.11% and a net margin of 7.60%.

Institutional Trading of Acacia Research

Institutional investors and hedge funds have recently modified their holdings of the business. AQR Capital Management LLC purchased a new stake in shares of Acacia Research during the first quarter valued at approximately $35,000. Pekin Hardy Strauss Inc. purchased a new stake in shares of Acacia Research during the fourth quarter valued at approximately $37,000. Zions Bancorporation National Association UT purchased a new stake in shares of Acacia Research during the fourth quarter valued at approximately $38,000. Sather Financial Group Inc purchased a new stake in shares of Acacia Research during the third quarter valued at approximately $48,000. Finally, Occudo Quantitative Strategies LP purchased a new stake in shares of Acacia Research during the fourth quarter valued at approximately $49,000. 86.69% of the stock is owned by hedge funds and other institutional investors.

About Acacia Research

(Get Free Report)

Acacia Research Corporation is a publicly traded patent licensing company based in New York City. The firm specializes in acquiring patented technologies through a network of wholly owned subsidiaries and seeking licensing agreements or settlements with companies that utilize those technologies. Since its founding in 1993, Acacia has built a business model centered on identifying innovative inventions and monetizing them through patent enforcement and strategic partnerships.

The company's activities span a broad range of technology sectors, including life sciences, medical devices, software, telecommunications and consumer electronics.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Acacia Research Right Now?

Before you consider Acacia Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acacia Research wasn't on the list.

While Acacia Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines